Get the Stockscreener App
0.7155
5.39%
0.0366
After Hours:
.75
0.0345
+4.82%
Rallybio Corp stock is traded at $0.7155, with a volume of 136.79K.
It is up +5.39% in the last 24 hours and up +8.11% over the past month.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
See More
Previous Close:
$0.6789
Open:
$0.676
24h Volume:
136.79K
Relative Volume:
0.63
Market Cap:
$30.23M
Revenue:
-
Net Income/Loss:
$-74.56M
P/E Ratio:
-0.3906
EPS:
-1.8316
Net Cash Flow:
$-60.27M
1W Performance:
+4.29%
1M Performance:
+8.11%
6M Performance:
+110.19%
1Y Performance:
-31.86%
1-Day Range:
$0.6759
$0.74
1-Week Range:
$0.665
$0.74
52-Week Range:
$0.2201
$1.04
Rallybio Corp Stock (RLYB) Company Profile
Name
Rallybio Corp
Sector
Industry
Phone
203- 859-3820
Address
234 CHURCH STREET, NEW HAVEN
Compare RLYB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.7155 | 28.68M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-07-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-17-23 | Initiated | H.C. Wainwright | Buy |
| Apr-10-23 | Initiated | Wedbush | Outperform |
| Dec-09-22 | Initiated | JP Morgan | Overweight |
| Feb-22-22 | Initiated | JMP Securities | Mkt Outperform |
| Aug-23-21 | Initiated | Cowen | Outperform |
| Aug-23-21 | Initiated | Evercore ISI | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
View All
Rallybio Corp Stock (RLYB) Latest News
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
What margin trends mean for Rallybio Corporation stockJuly 2025 Catalysts & Weekly Stock Performance Updates - moha.gov.vn
Rallybio seeks reverse stock split to maintain Nasdaq listing - Hartford Business Journal
US Market Wrap: Why Rallybio Corporation stock is a value investor pickJuly 2025 Price Swings & High Accuracy Trade Alerts - moha.gov.vn
Will Rallybio Corporation stock outperform Dow Jones index2025 Market Overview & Daily Market Momentum Tracking - Улправда
Why analysts upgrade Rallybio Corporation stockWeekly Trend Recap & Weekly Momentum Stock Picks - Улправда
Brokerages Set Rallybio Corporation (NASDAQ:RLYB) PT at $5.00 - Defense World
Jobs Data: Can Rallybio Corporation stock double in next 5 yearsEarnings Risk Summary & Fast Moving Trade Plans - Улправда
US Stocks Recap: Will Rallybio Corporation stock deliver shareholder value2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Why Rallybio Corporation stock is a value investor pickDividend Hike & Daily Momentum Trading Reports - DonanımHaber
How risky is Rallybio Corporation stock nowQuarterly Market Review & Growth Focused Stock Reports - DonanımHaber
Can Rallybio Corporation stock double in next 5 yearsPortfolio Growth Summary & Weekly Watchlist of Top Performers - Улправда
Will Rallybio Corporation stock deliver shareholder value2025 Technical Overview & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Aug PostEarnings: Why analysts upgrade Rallybio Corporation stock2025 AllTime Highs & Capital Protection Trade Alerts - Улправда
Rallybio (NASDAQ:RLYB) Stock Price Up 5.1% – Still a Buy? - Defense World
Breakouts Watch: Why Rallybio Corporation stock could outperform in 2025July 2025 Review & Consistent Profit Focused Trading Strategies - moha.gov.vn
Will Rallybio Corporation stock deliver consistent dividendsBull Run & Growth-Oriented Investment Plans - Newser
Will Rallybio Corporation stock split attract more investorsPortfolio Risk Summary & Risk Adjusted Swing Trade Ideas - Newser
Is Rallybio Corporation stock attractive for passive investorsTrade Volume Summary & Short-Term High Return Ideas - Newser
Why Rallybio Corporation stock could outperform in 2025Quarterly Risk Review & Weekly Momentum Stock Picks - Newser
Check out these key findings about Rallybio Corp (RLYB) - Setenews
Rallybio Corporation (RLYB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Rallybio Corporation stock maintain momentum in 2025July 2025 EndofMonth & Daily Profit Focused Screening - newser.com
Will Rallybio Corporation stock sustain high P E ratiosJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com
Why retail investors favor Rallybio Corporation stockEntry Point & Long-Term Safe Investment Plans - newser.com
Does Rallybio Corporation fit your quant trading modelOil Prices & Short-Term High Return Ideas - newser.com
Rallybio CorporationCommon Stock (Nasdaq:RLYB) Stock Quote - Markets Financial Content
Is Rallybio Corporation trending in predictive chart modelsMarket Trend Review & Precise Buy Zone Tips - newser.com
Technical signs of recovery in Rallybio CorporationJuly 2025 Highlights & Free Verified High Yield Trade Plans - newser.com
Published on: 2025-11-18 05:40:40 - newser.com
Is Rallybio Corporation stock reversal real or fakeGap Up & Safe Entry Trade Signal Reports - newser.com
Strategies to average down on Rallybio CorporationVolume Spike & Technical Confirmation Trade Alerts - newser.com
Will Rallybio Corporation stock beat EPS estimatesQuarterly Portfolio Review & Safe Swing Trade Setups - newser.com
Published on: 2025-11-13 18:12:20 - newser.com
Rallybio Corp Stock (RLYB) Financials Data
Revenue
Net Income
Cash Flow
EPS
28.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):